|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been received by the manufacturer for evaluation.Each event reported to bd is evaluated and investigated in accordance with our complaint investigation procedures.The investigation process includes, but is not limited to, evaluation of the event details provided by the complaint facility, a review of complaint history, manufacturing records and risk document where applicable, and an evaluation of the subject device when available to identify potential contributing factors.
|
|
It was reported patient came to clinic for abraxane infusion via port.Patient's port was accessed.No leaking noted during the infusion, but with flushing the port after the infusion, it was noted that fluid was leaking where the clave connects on to the end of the port tubing.The leaking only happened with flushing the port with saline, not during the chemo treatment.
|